Life Science Leader Magazine Supplements

CMO Leadership Awards 2012

The vision of Life Science Leader is to be an essential business tool for life science executives. Our content is designed to not only inform readers of best practices, but motivate them to implement those best practices in their own businesses.

Issue link: https://lifescienceleadermag.epubxp.com/i/85321

Contents of this Issue

Navigation

Page 38 of 59

DRUG TYPE: Pharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development – pre-clinical and clinical (phase 1, phase 2, and phase 3) Drug Substance Production – primary process development and drug substance production Formulated Drug Production – dosage form development, dosage form production, and packaging SERVICES OFFERED: Aseptic fill/finish, controlled substances, creams & ointments, gels, injectables, liquids, non-sterile, ophthalmics, OTC, parenterals (small volume), semisolids, solutions & suspensions, sterile, sustained release, and topicals. "DPT continues to evolve in innovation by adding capabilities that complement what we do best, providing industry-leading development and manufacturing services in sterile and non-sterile semi-solids and liquids. We monitor market trends, strive to understand current and potential challenges, and respond to changing needs. Our vision emphasizes innovation, high-quality service, and the best technology. Our goal is to be the best at what we do, with success defined by customer satisfaction." — Paul Johnson, DPT Group president & COO Ei Inc. Kannapolis, NC www.eisolutionworks.com (704) 939-4300 DRUG TYPE: Pharmaceuticals and Biopharmaceuticals DRUG LIFE CYCLE STAGES: Formulated Drug Production – dosage form development, dosage form production, and packaging Manufacturing locations: Kannapolis, NC, and Landis, NC Contact: Diana Ritch dritch@eisolutionworks.com DRUG TYPE: Pharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development – pre-clinical and clinical (phase 1, phase 2, and phase 3) Drug Substance Production – primary process development and drug substance production Formulated Drug Production – dosage form development, dosage form production, and packaging SERVICES OFFERED: Aseptic fill/finish, capsules, controlled substances, cytotoxic & high-potency compounds, generics, injectables, liquids, lyophilized products, ophthalmics, OTC, parenterals (large volume), parenterals (small volume), proteins, solid dose, sterile, sustained release, and vaccines. "DSM is honored to receive a CMO Leadership Award based on the fact that the awards represent the opinions of the customer, pharmaceutical, and biopharmaceutical companies who are using our services. To be recognized in the innovation category is truly an honor." —Alexander R. Wessels, MSc, MBA, chief executive officer DPT Laboratories San Antonio, TX www.DPTLabs.com (866) CALL-DPT [225-5378] Manufacturing locations: Lakewood, NJ, and San Antonio, TX Contact: Craig Zabojnik craig.zabojnik@dptlabs.com DSM Pharmaceutical Products Parsippany, NJ www.dsm.com/pharma (973) 257-8160 DRUG TYPE: Pharmaceuticals and Biopharmaceuticals Manufacturing locations: Australia (2013), Austria, Germany, Italy, The Netherlands, and The United States Contact: Hank Nowak hank.nowak@dsm.com Euticals SPA Rozzano, Milan, Italy www.euticals.com 3902 8227 2214 Manufacturing locations: France, Germany, Italy, United Kingdom, and United States Contact: Varadaraj Elango v.elango@euticals.com DRUG LIFE CYCLE STAGES: Research & Development – clinical (phase 1, phase 2, and phase 3) Drug Substance Production – drug substance production Formulated Drug Production – dosage form production SERVICES OFFERED: Creams & ointments, cytotoxic & high-potency compounds, gels, generics, non-sterile, OTC, powders (non-sterile), semisolids, solutions & suspensions, and topicals. SERVICES OFFERED: Controlled substances, cytotoxic & high-potency compounds, generics, injectables, lyophilized products, non-sterile, OTC, peptides, powders (non-sterile), and powders (sterile). ""Ei is honored to be recognized as a top tier organization and industry leader. We have a singular goal to improve products, strengthen brands, and create better lives by setting a new standard in topical pharmaceutical development and manufacturing. This is accomplished through cutting- edge science and state-of-the-art manufacturing wielded by people who understand that, although we provide a product, what we really do is protect a brand." — Michael Kane, president & CEO The CMO Leadership Awards 2012 39 DRUG LIFE CYCLE STAGES

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CMO Leadership Awards 2012